182 related articles for article (PubMed ID: 29220792)
1. 4-Quinolone derivatives and their activities against Gram positive pathogens.
Zhang GF; Zhang S; Pan B; Liu X; Feng LS
Eur J Med Chem; 2018 Jan; 143():710-723. PubMed ID: 29220792
[TBL] [Abstract][Full Text] [Related]
2. 4-Quinolone hybrids and their antibacterial activities.
Hu YQ; Zhang S; Xu Z; Lv ZS; Liu ML; Feng LS
Eur J Med Chem; 2017 Dec; 141():335-345. PubMed ID: 29031077
[TBL] [Abstract][Full Text] [Related]
3. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin derivatives and their antibacterial activities.
Zhang GF; Liu X; Zhang S; Pan B; Liu ML
Eur J Med Chem; 2018 Feb; 146():599-612. PubMed ID: 29407984
[TBL] [Abstract][Full Text] [Related]
5. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
[TBL] [Abstract][Full Text] [Related]
6. [Synthesis and antibacterial activity of dl-7-(4,4-dimethyl-3-aminomethylpyrrolidinyl) -quinolones].
Wang YC; Wang XY; Liu JY; Guo HY
Yao Xue Xue Bao; 2006 Jan; 41(1):58-64. PubMed ID: 16683529
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antibacterial activity of quinolone/naphthyridone derivatives containing 3-alkoxyimino-4-(methyl)aminopiperidine scaffolds.
Lv K; Wu J; Wang J; Liu M; Wei Z; Cao J; Sun Y; Guo H
Bioorg Med Chem Lett; 2013 Mar; 23(6):1754-9. PubMed ID: 23402878
[TBL] [Abstract][Full Text] [Related]
8. Recent developments of quinolone-based derivatives and their activities against Escherichia coli.
Gao F; Wang P; Yang H; Miao Q; Ma L; Lu G
Eur J Med Chem; 2018 Sep; 157():1223-1248. PubMed ID: 30193220
[TBL] [Abstract][Full Text] [Related]
9. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
Kocsis B; Domokos J; Szabo D
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
11. Pleuromutilin derivatives having a purine ring. Part 1: new compounds with promising antibacterial activity against resistant Gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakamura T; Fujimoto K; Kashimoto S; Kojima T; Kato S
Bioorg Med Chem Lett; 2008 Jun; 18(12):3556-61. PubMed ID: 18511280
[TBL] [Abstract][Full Text] [Related]
12. 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.
Zhang J; Wang S; Ba Y; Xu Z
Eur J Med Chem; 2019 Jul; 174():1-8. PubMed ID: 31015103
[TBL] [Abstract][Full Text] [Related]
13. Novel antibacterial active quinolone-fluoroquinolone conjugates and 2D-QSAR studies.
Panda SS; Liaqat S; Girgis AS; Samir A; Hall CD; Katritzky AR
Bioorg Med Chem Lett; 2015 Sep; 25(18):3816-21. PubMed ID: 26253630
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives.
Zhang Z; Yu A; Zhou W
Bioorg Med Chem; 2007 Dec; 15(23):7274-80. PubMed ID: 17826097
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
[TBL] [Abstract][Full Text] [Related]
17. [The possibility of drug design of quinolones effective for multiresistant gram-positive pathogens].
Hayakawa I
Nihon Rinsho; 1997 May; 55(5):1266-71. PubMed ID: 9155185
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
Wang XY; Guo Q; Wang YC; Liu BQ; Liu ML; Sun LY; Guo HY
Yao Xue Xue Bao; 2008 Aug; 43(8):819-27. PubMed ID: 18956774
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.
López Y; Tato M; Espinal P; Garcia-Alonso F; Gargallo-Viola D; Cantón R; Vila J
Antimicrob Agents Chemother; 2013 Dec; 57(12):6389-92. PubMed ID: 24080666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
